Page last updated: 2024-10-23

bepridil and Liver Diseases

bepridil has been researched along with Liver Diseases in 2 studies

Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.

Liver Diseases: Pathological processes of the LIVER.

Research Excerpts

ExcerptRelevanceReference
" These products are well absorbed from the gastrointestinal tract but undergo variable degrees of transformation during the first passage through the liver."2.37[Clinical pharmacology of calcium inhibitors]. ( Martre, H; Singlas, E; Taburet, AM, 1985)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gyamfi, MA1
Yonamine, M1
Aniya, Y1
Singlas, E1
Martre, H1
Taburet, AM1

Reviews

1 review available for bepridil and Liver Diseases

ArticleYear
[Clinical pharmacology of calcium inhibitors].
    Archives des maladies du coeur et des vaisseaux, 1985, Volume: 78 Spec No

    Topics: Age Factors; Animals; Bepridil; Biological Availability; Biotransformation; Calcium Channel Blockers

1985

Other Studies

1 other study available for bepridil and Liver Diseases

ArticleYear
Free-radical scavenging action of medicinal herbs from Ghana: Thonningia sanguinea on experimentally-induced liver injuries.
    General pharmacology, 1999, Volume: 32, Issue:6

    Topics: Alanine Transaminase; Aniline Hydroxylase; Animals; Antioxidants; Aspartate Aminotransferases; Bepri

1999